Mettler Toledo's revenue has grown by 5.5% a year over the last 5 years – slower than the median of the Health Care sector (+8.5%). The net margin in the last fiscal year was 21.6%, the sector median 13.9%. The 52-week high is 8.4% away (close of Nov 20, 2026).
Metrics from daily candles, as of Nov 20, 2026
· Extended universe
Live quote by TradingView
One click loads all TradingView content on this page. Data (including your IP address) is sent to TradingView, also to the USA. Privacy
Prices: TradingView (stock prices delayed).
Figures in the price bar from TradingView (mostly trailing 12 months) · our fundamental analysis uses the fiscal year
At a glance: figures and chart
3 strengths · 1 weakness · Fiscal year to Dec 31, 2025
Quality checks from the annual figures and, separately, the position of the price relative to the 200-day line. No overall score.
Quality5 of 6 criteria with data met · 2 without data
Growth5 of 7 criteria with data met
Dividend0 of 1 criteria with data met · 6 without data
Financial strength4 of 6 criteria with data met
Chart positionbelow200-day lineabovemore than 10% above – position relative to the 200-day line
Strengths well above the threshold
+Net margin21.6%Threshold: above 10% · Distance +11.6 pp · Sector median 12.9% (63 stocks) · Fiscal year to Dec 31, 2025
+Free cash flow margin21.1%Threshold: above 10% · Distance +11.1 pp · Sector median 14.5% (61 stocks) · Fiscal year to Dec 31, 2025
+EPS growth 5 years+11.0% per yearThreshold: above 5% per year · Distance +6.0 pp · Sector median +8.3% per year (47 stocks) · Fiscal year to Dec 31, 2025
Weaknesses well below the threshold
−Equity−23.6M USDThreshold: above 0 · Fiscal year to Dec 31, 2025
On the radar
Position relative to the 200-day line: more than 10% above (as of Nov 20, 2026)
What we do not know
Data missing: 2 of 28 criteria not stated in the SEC filings (Fiscal year to Dec 31, 2025).
Operating margin above 15%
Return on equity above 15%
Not applicable
Pays no dividend – the dividend criteria do not apply (Fiscal year to Dec 31, 2025).
Return on equity and debt / equity: not computable because equity is negative (Fiscal year to Dec 31, 2025).
How is this made? · Created on Nov 22, 2026 from fixed rules · not investment advice
Load chart from TradingView
This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.
Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Academy: 200-day line · RSI
About the company
Mettler Toledo is a maker of precision balances and lab instruments with roots in Switzerland. The company supplies lab balances, analytical instruments, industrial scales and inspection systems for production lines, for example in pharma, chemicals and food. As of Oct 11, 2026
As of Oct 11, 2026Fact sheet (from the annual report)Laboratory instruments · Columbus, USAfull fact sheet
The company makes precision instruments and offers related services. In the lab, its products range from balances and pipettes to titrators and pH meters and software for data analysis. For manufacturers there are inspection systems such as metal detectors, X-ray systems, checkweighers and cameras at the end of the production line. Supermarkets and other food retailers use scales and labeling solutions for fresh goods. Its customers include pharma and biotechnology, food manufacturers, chemicals, universities and food retail. As a rule, technically sophisticated instruments are sold through its own field sales force and simpler ones through indirect channels.
This symbol belongs to the extended universe: we load daily candles only and show metrics, fundamentals and an overview – chart methods and Elliott analysis are not available for it.
Calculated automatically by fixed rules – not investment advice, check for yourself. How we analyze
Price performance at a glance
Last 30 trading days
Today−2.3%
7 days−4.1%
30 days−0.7%
1 year+19.1%
Day range (last trading day)
−0.1%Price at 4% of the range+3.2%
52-week range
−38.6%Price at 82% of the range+8.4%
Distance from the all-time high
−7.7%
Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Chart analysis: trend by timeframe
Trend by timeframeFor each timeframe (week, day, 4 hours): up when the close is above the SMA 200, the EMA 20 above the EMA 50 and the structure shows higher highs and lows. Down the other way round, otherwise mixed. No score, no forecast.Example: Week up, day up, 4 hours mixed → not aligned.More in the Academy: Lesson trend and market structure
1Wweekly candles↗ up
Close above the SMA 200
EMA 20 above the EMA 50
higher highs and higher lows
Price above the EMA 20 · above the EMA 50
Week to Nov 20, 2026
1Ddaily candles↗ up
Close above the SMA 200
EMA 20 above the EMA 50
higher highs and higher lows
Price below the EMA 20 · above the EMA 50
Daily candle of Nov 20, 2026
4H4-hour candles– not available
No value on 4 hours (too few or no checked 4-hour candles).
Rule per timeframe: up = close above the SMA 200, EMA 20 above the EMA 50 and higher highs and lows; down = everything the other way round; otherwise mixed. Completed candles only, no overall score, no forecast. In the screener: all three up →
What does the daily chart show right now – line by line, without an overall verdict?
Technicals in plain words
Technicals in plain wordsFour lines on the daily chart – trend, momentum, volume, volatility –, each with its metric and threshold. We do not add the lines up or give a grade; they describe the price history so far.Example: RSI 64 → between 30 and 70, neither overbought nor oversold.More in the Academy: Lesson reading the RSI
Over the last 3 months it ran stronger than the S&P 500 and stronger than the median of the sector “Health Care”.
vs. S&P 500 · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
vs. S&P 500 · 6 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
vs. sector · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
stronger
Trendabove SMA 200Price above the 200-day line – above it the long-term trend counts as up; ADX above 25 – a pronounced trend.
MomentumneutralRSI between 30 and 70 – neither overbought nor oversold; MACD line below its signal line (gap below 0).
Volumenot elevatedVolume on the last trading day below 1.5 times the average of up to 50 trading days before – not elevated.
VolatilitynormalTypical daily range (ATR 14) between 2 and 4% of the price – normal; Bollinger Bands as narrow as on at most one fifth of the last 120 trading days (squeeze).
The figures behind it – distance to the line, RSI, volume, volatility and relative strength in percentage points – are visible with a free account.Sign up free
More depth
How we read the lines
Each line stands on its own – we do not add them up and give no grade.
Trend: the 200-day line is the average of the last 200 closing prices. The ADX (14) measures how pronounced a trend is, not its direction: below 20 hardly any trend, above 25 pronounced.
Momentum: the RSI (14) lies between 0 and 100; below 30 it counts as oversold, above 70 as overbought. The MACD (12/26) compares two averages, the signal line (9) smooths it.
Volume: shares traded on the last trading day divided by the average of up to 50 trading days before; from 1.5x elevated, from 2x unusually high, from 3x very high.
Volatility: typical daily range (ATR 14) as a percentage of the price; below 2% calm, 2 to 4% normal, above 4% high. Squeeze = Bollinger Bands as narrow as on at most a fifth of the last 120 trading days.
Relative strength: the stock’s price change minus that of the benchmark over the same period (3 months = 91 days, 6 months = 182 days), in percentage points, from completed daily candles. Benchmark: the S&P 500 (ETF SPY) or the median of the stocks of the same sector in our selection (at least 5 others with a candle on the same day). Dividends are not included.
Against the sector median over 6 months: ran stronger.
All figures describe the price history so far – they do not say what happens next.
As of: daily candle of Nov 20, 2026 · from our daily candles
How did this asset do in each calendar month over the last 10 years?
Seasonality
SeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
In November, the stock closed higher in 8 of 10 years – the S&P 500 in 9 of 10.
Years higher in NovemberSeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
8 of 10
2016 to 2025
S&P 500 in November
9 of 10
years higher, same years as above (ETF SPY)
Months mostly higher
5 of 12
Calendar months that closed higher in more than half of the years
You can see the median and range per month in percent with a free account.Sign up free
6/10Jan
3/10Feb
5/10Mar
5/10Apr
5/10May
7/10Jun
7/10Jul
4/10Aug
5/10Sep
7/10Oct
8/10Nov
4/10Dec
January: higher in 6 of 10 years
February: higher in 3 of 10 years
March: higher in 5 of 10 years
April: higher in 5 of 10 years
May: higher in 5 of 10 years
June: higher in 7 of 10 years
July: higher in 7 of 10 years
August: higher in 4 of 10 years
September: higher in 5 of 10 years
October: higher in 7 of 10 years
November (current month): higher in 8 of 10 years
December: higher in 4 of 10 years
Past performance, not a forecast · Bar = share of years higher, line = half · Price return without dividendsMore depth
How we calculate
Monthly return = closing price on the last trading day of the month ÷ closing price on the last trading day of the previous month − 1. Price return without dividends.
Only completed months count, never the current one. If the candle of the last trading day is missing, the month does not count.
For each calendar month the last 10 years in which it has ended; from 8 years with a value we show the median, years higher and the range. “Higher” means: return above 0.0%.
Past performance, not a forecast: the figures describe earlier years and do not tell how the next month will go.
By calendar month (● = current month)
Month
Years higher
January
6 of 10
February
3 of 10
March
5 of 10
April
5 of 10
May
5 of 10
June
7 of 10
July
7 of 10
August
4 of 10
September
5 of 10
October
7 of 10
November ●
8 of 10
December
4 of 10
Through October 2026 (last completed month) · from our daily candles
Fundamental analysis
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Mettler Toledo · Sector Health Care · amounts in USD
Source: SEC filings, As of Feb 6, 2026.
Investor typeInvestor type (“lens”)You choose which style comes first: dividends, valuation, growth, quality or trading. Screener and stock page then show suggestions and “For you first”, with an account also matching columns and order. The lens unlocks nothing and changes no matches.Example: Lens “Dividends” → on the stock page first the streak without a cut, growth and cover of the dividend.More in the Academy: Guide fundamental analysis
Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.
–no data: Operating margin above 15%not stated in the SEC filings
✓met: Net margin above 10%21.6%
–no data: Return on equity above 15%negative equity
✓met: Free cash flow margin above 10%21.1%
✓met: Profit in each of the last 5 fiscal years5 of 5
✓met: Free cash flow positive in each of the last 3 fiscal years3 of 3
✗not met: Equity ratio above 30%−0.6%
Gross margin
59.4%Fiscal year 2025
All68strong
Rank 68 of 100: higher than 68% of 370 peers (All). strong.
Sector44medium
Rank 44 of 100: higher than 44% of 49 peers (Sector). medium.
Median Health Care: 61.8%
Share of revenue left after the direct cost of the products sold.
Net margin
21.6%Fiscal year 2025
All81strong
Rank 81 of 100: higher than 81% of 584 peers (All). strong.
Sector79strong
Rank 79 of 100: higher than 79% of 63 peers (Sector). strong.
Median Health Care: 12.9%
Profit after all costs, interest and taxes divided by revenue.
Return on assets
23.4%Fiscal year 2025 (total assets at year end)
All96strong
Rank 96 of 100: higher than 96% of 594 peers (All). strong.
Sector96strong
Rank 96 of 100: higher than 96% of 63 peers (Sector). strong.
Median Health Care: 6.6%
Net income divided by total assets at fiscal year end.
Equity ratio
−0.6%Fiscal year 2025
All6weak
Rank 6 of 100: higher than 6% of 595 peers (All). weak.
Sector12weak
Rank 12 of 100: higher than 12% of 63 peers (Sector). weak.
Median Health Care: 44.2%
Equity as a share of total assets. Usually low for banks.
Free cash flow margin
21.1%Fiscal year 2025
All79strong
Rank 79 of 100: higher than 79% of 465 peers (All). strong.
Sector73strong
Rank 73 of 100: higher than 73% of 61 peers (Sector). strong.
Median Health Care: 14.5%
Free cash flow divided by revenue.
Free cash flow
848.6M USDFiscal year 2025
Operating cash flow minus capital expenditure on property and equipment.
Growth 5 of 7 met
✗not met: Over 3 years, revenue grew by more than 5% per year+0.9%
✓met: Over 5 years, revenue grew by more than 5% per year+5.5%
✓met: Over 10 years, revenue grew by more than 5% per year+5.3%
✗not met: Over 3 years, EPS grew by more than 5% per year+3.1%
✓met: Over 5 years, EPS grew by more than 5% per year+11.0%
✓met: Revenue rose in at least 4 of the last 5 fiscal years4 of 5
✓met: Revenue rose in the last fiscal year+4.0%
Revenue growth 3 years
+0.9%per year
All25weak
Rank 25 of 100: higher than 25% of 578 peers (All). weak.
Sector27weak
Rank 27 of 100: higher than 27% of 62 peers (Sector). weak.
Median Health Care: +5.1%
Average growth per year over 3 fiscal years.
Revenue growth 5 years
+5.5%per year
All30weak
Rank 30 of 100: higher than 30% of 549 peers (All). weak.
Sector31weak
Rank 31 of 100: higher than 31% of 60 peers (Sector). weak.
Median Health Care: +7.8%
Average growth per year over 5 fiscal years.
Revenue growth 10 years
+5.3%per year
All40medium
Rank 40 of 100: higher than 40% of 412 peers (All). medium.
Sector21weak
Rank 21 of 100: higher than 21% of 50 peers (Sector). weak.
Median Health Care: +9.3%
Average growth per year over 10 fiscal years.
EPS growth 3 years
+3.1%per year
All39medium
Rank 39 of 100: higher than 39% of 437 peers (All). medium.
Sector45medium
Rank 45 of 100: higher than 45% of 54 peers (Sector). medium.
Median Health Care: +5.0%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 5 years
+11.0%per year
All48medium
Rank 48 of 100: higher than 48% of 399 peers (All). medium.
Sector61medium
Rank 61 of 100: higher than 61% of 47 peers (Sector). medium.
Median Health Care: +8.3%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 10 years
+12.9%per year
All65medium
Rank 65 of 100: higher than 65% of 375 peers (All). medium.
Sector60medium
Rank 60 of 100: higher than 60% of 46 peers (Sector). medium.
Median Health Care: +9.3%
Growth of earnings per share per year, adjusted for stock splits.
Dividend 0 of 1 met · 6 without data
✗not met: Pays a dividendno dividend per share reported for the last fiscal year
–no data: Payout ratio at most 60% of earningspays no dividend
–no data: Dividend paid in each of the last 5 fiscal yearspays no dividend
–no data: Dividend per share never lowered in the last 5 fiscal yearspays no dividend
–no data: Dividend per share higher than 5 years agopays no dividend
–no data: Free cash flow per share covers the dividendpays no dividend
–no data: Dividends paid over the last 5 years covered by free cash flowpays no dividend
Financial strength 4 of 6 met
✓met: Piotroski F-Score at least 7 of 98 of 9
✗not met: Long-term debt no higher than equitynegative equity
✓met: Current assets cover current liabilities1.14
✗not met: Positive equity−23.6M USD
✓met: In 5 years, share count up by at most 5%−14.6%
✓met: Free cash flow positive in the last fiscal year848.6M USD
Piotroski F-Score
8 of 9Fiscal year 2025
All88strong
Rank 88 of 100: higher than 88% of 310 peers (All). strong.
Sector85strong
Rank 85 of 100: higher than 85% of 47 peers (Sector). strong.
Median Health Care: 6.0 of 9
Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.
Debt / equity
negative equityat fiscal year end
No rank: too few peers or not computed yet.
Long-term financial debt divided by equity.
Liquidity (current ratio)
1.14at fiscal year end
All38medium
Rank 38 of 100: higher than 38% of 513 peers (All). medium.
Sector23weak
Rank 23 of 100: higher than 23% of 63 peers (Sector). weak.
Median Health Care: 1.58
Current assets divided by current liabilities.
Change in share count
−14.6%in 5 years
All85strong
Rank 85 of 100: lower than 85% of 507 peers (All). strong.
Sector84strong
Rank 84 of 100: lower than 84% of 59 peers (Sector). strong.
Median Health Care: −4.3%
Change in diluted share count. Negative = share buybacks, positive = new shares.
The 9 criteria of the Piotroski F-Score
✓met: Profit in the last fiscal year (positive return on assets)
✓met: Positive operating cash flow
✓met: Return on assets higher than the prior year
✓met: Operating cash flow higher than net income
✓met: Long-term debt relative to total assets fell
✓met: Liquidity (current assets / current liabilities) rose
✓met: No additional shares (diluted share count did not rise)
✗not met: Gross margin higher than the prior year
✓met: Revenue relative to total assets higher than the prior year
Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.
Price-based criteria (P/E, dividend yield) are shown to signed-in users.
Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.
In short
Light yellow: Revenue grew over 5 years (+5.5% per year), more slowly than the sector median.
Light green: Net income (total) grew over 5 years (+7.6% per year), at least as fast as the sector median; per share +11.0% per year.
Light green: Net margin 21.6%, above the sector median (13.9%).
Light red: Debt much higher than usual in the sector.
Light green: Profit in each of the last 10 fiscal years.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
02B4B6B
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 2.5B USD · Net income 384.4M USD · Net margin 15.3%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 2.7B USD · Net income 376.0M USD · Net margin 13.8%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 2.9B USD · Net income 512.6M USD · Net margin 17.5%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 3.0B USD · Net income 561.1M USD · Net margin 18.6%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 3.1B USD · Net income 602.7M USD · Net margin 19.5%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 3.7B USD · Net income 769.0M USD · Net margin 20.7%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 3.9B USD · Net income 872.5M USD · Net margin 22.3%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 3.8B USD · Net income 788.8M USD · Net margin 20.8%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 3.9B USD · Net income 863.1M USD · Net margin 22.3%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 4.0B USD · Net income 869.2M USD · Net margin 21.6%
Margin
15%14%17%19%20%21%22%21%22%22%
RevenueNet incomeNet margin (below)in USD
0500M1B1.5B
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 935.0M USD · Net income 184.8M USD · Net margin 19.8% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 925.9M USD · Net income 177.5M USD · Net margin 19.2%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue 946.8M USD · Net income 221.8M USD · Net margin 23.4%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 954.5M USD · Net income 211.5M USD · Net margin 22.2%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 1.0B USD · Net income 252.3M USD · Net margin 24.1% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 883.7M USD · Net income 163.6M USD · Net margin 18.5%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 983.2M USD · Net income 202.3M USD · Net margin 20.6%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 1.0B USD · Net income 217.5M USD · Net margin 21.1%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 1.1B USD · Net income 285.8M USD · Net margin 25.3% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Revenue 947.1M USD · Net income 169.5M USD · Net margin 17.9%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Revenue 1.0B USD · Net income 232.9M USD · Net margin 22.7%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Revenue 1.1B USD · Net income 246.0M USD · Net margin 22.5%
Margin
20%19%23%22%24%19%21%21%25%18%23%22%
Earnings per shareUSD per share
0204060
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Earnings per share 14.22 USD
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Earnings per share 14.24 USD
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Earnings per share 19.88 USD
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Earnings per share 22.47 USD
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Earnings per share 24.91 USD
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Earnings per share 32.78 USD
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Earnings per share 38.41 USD
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Earnings per share 35.90 USD
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Earnings per share 40.48 USD
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Earnings per share 42.05 USD
Earnings per shareUSD per share
05.001015
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Earnings per share not reported separately for Q4
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Earnings per share 8.24 USD
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Earnings per share 10.37 USD
No reported values for “Dividend per share” in this interval.
No reported values for “Dividend per share” in this interval.
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 4.0B USD · Net income 869.2M USD · Net margin 21.6%
How has it gone since the last annual report?
Trailing 12 months and quarters
Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Revenue in the quarter to Sep 2026 +6.3% vs. the same quarter a year earlier; grown for 6 quarters in a row.
Revenue 12 months vs. prior 12Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Free cash flow margin 12 monthsFree cash flowCash from operations minus investment in property, plant and equipment. It shows how much money is left over – for repaying debt, dividends or share repurchases.Example: Operating cash flow 120 million euros, investments 45 million euros → free cash flow 75 million euros.More in the Academy: Guide fundamental analysis
20.7%
Fiscal year 2025: 21.1%
More depth
Calculation of the 12 months to Sep 30, 2026
Revenue: fiscal year to Dec 31, 2025 4.0B USD + year to date to Sep 30, 2026 3.1B USD − same period a year earlier to Sep 30, 2025 2.9B USD = 4.2B USD
Net income: fiscal year to Dec 31, 2025 869.2M USD + year to date to Sep 30, 2026 648.3M USD − same period a year earlier to Sep 30, 2025 583.4M USD = 934.1M USD
Operating cash flow: fiscal year to Dec 31, 2025 955.8M USD + year to date to Sep 30, 2026 758.8M USD − same period a year earlier to Sep 30, 2025 730.2M USD = 984.4M USD
Capital expenditure: fiscal year to Dec 31, 2025 107.1M USD + year to date to Sep 30, 2026 72.3M USD − same period a year earlier to Sep 30, 2025 65.6M USD = 113.8M USD
By quarter (latest first, amounts in USD)
Quarter
Revenue
vs. year ago
Net income
Margin
Jul–Sep 26
1.1B
+6.3%
246.0M
22.5%
Apr–Jun 26
1.0B
+4.5%
232.9M
22.7%
Jan–Mar 26
947.1M
+7.2%
169.5M
17.9%
Oct–Dec 25*
1.1B
+8.1%
285.8M
25.3%
Jul–Sep 25
1.0B
+7.9%
217.5M
21.1%
Apr–Jun 25
983.2M
+3.9%
202.3M
20.6%
Jan–Mar 25
883.7M
−4.6%
163.6M
18.5%
Oct–Dec 24*
1.0B
+11.8%
252.3M
24.1%
Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.
Each quarter is compared with the same quarter a year earlier.
* derived: fiscal year minus the first 9 months.
As of: 12 months to Sep 30, 2026, filed on Nov 6, 2026 · Source: SEC filings (10-Q, 10-K)
Does the profit arrive as cash?
Earnings quality
Profit is backed by cash; interest is well covered.
Cash flow ÷ profitCash flow ÷ profitOperating cash flow divided by group profit. From 1.0, at least as much cash came in as profit was reported; below that, profit may sit in receivables or inventories, and non-cash gains or one-off payments also push the ratio down. Depreciation and stock-based pay lift it.Example: Operating cash flow €120m, group profit €100m → 1.20x.More in the Academy: Lesson earnings quality
1.10x
0.81.0
backed from 1.0 · 3 years: 1.15x
Interest coverageInterest coverageOperating income divided by interest expense: how many times the core business earns its interest. From 5x we count interest as well covered, below 2x as thinly covered.Example: Operating income €50m, interest expense €5m → 10.0x.More in the Academy: Lesson earnings quality
16.3x
25
well covered from 5 · EBIT, derived · 3 years: 14.9x
Tax rateTax rateIncome taxes divided by profit before tax, in percent. If the SEC data lack it, we approximate it as group profit plus taxes; minority interests, discontinued operations, one-off items and tax credits can shift the rate.Example: Taxes €21m, net income €79m → 21 : 100 = 21%.More in the Academy: Lesson earnings quality
17.1%
for information only · 3 years: 17.6%
More depth
Calculation for fiscal year 2025
Operating cash flow 955.8M USD ÷ Net income 869.2M USD = 1.10x
EBIT, derived (profit before tax plus interest expense) 1.1B USD ÷ Interest expense 68.5M USD = 16.3x
How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.
Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.
As of fiscal year 2025 · Source: SEC filings
How even were the last years?
Consistency
In 10 fiscal years no loss year and one year with lower revenue.
Loss yearsLoss yearsFiscal years that ended with a loss on the bottom line (net income below zero). Few loss years over a long period show how evenly a company has earned so far – they say nothing about the future.Example: Loss only in fiscal year 2020 → 1 of 10.More in the Academy: Lesson revenue, profit and margin
0 of 10
net income below zero
Years with lower revenueYear with lower revenueA fiscal year in which revenue was lower than in the prior year. Only years for which the prior year’s revenue is also reported are counted.Example: Revenue 100 → €96m → one year with lower revenue.More in the Academy: Lesson revenue, profit and margin
1 of 10
revenue below the prior year
Net margin rangeNet margin rangeHighest minus lowest net margin of the fiscal years shown, in percentage points. A small range means the share of profit in revenue stayed similar over the years.Example: Net margins between 18.2% and 26.4% → range 8.2 percentage points.More in the Academy: Lesson revenue, profit and margin
8.5 percentage points
from 13.8% to 22.3%
▾20162025Net margin by fiscal year · ▾ revenue below the prior yearMore depth
By fiscal year
FY
Revenue vs. prior year
Net margin
2025
+4.0%
21.6%
2024
+2.2%
22.3%
2023
−3.4%
20.8%
2022
+5.4%
22.3%
2021
+20.5%
20.7%
2020
+2.5%
19.5%
2019
+2.5%
18.6%
2018
+7.7%
17.5%
2017
+8.6%
13.8%
2016
+4.7%
15.3%
Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.
As of fiscal years 2016–2025 · Source: SEC filings
Figures over time
Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.
Money flow in fiscal year 2025
Of 100 USD of revenue, 59.4 USD gross profit and 21.6 USD net income remained.
2016Fiscal year 2016: Operating cash flow 443.1M USD · Capital expenditure 124.0M USD · Free cash flow 319.1M USD
2017Fiscal year 2017: Operating cash flow 516.3M USD · Capital expenditure 127.4M USD · Free cash flow 388.9M USD
2018Fiscal year 2018: Operating cash flow 565.0M USD · Capital expenditure 142.7M USD · Free cash flow 422.3M USD
2019Fiscal year 2019: Operating cash flow 603.5M USD · Capital expenditure 97.3M USD · Free cash flow 506.1M USD
2020Fiscal year 2020: Operating cash flow 724.7M USD · Capital expenditure 92.5M USD · Free cash flow 632.2M USD
2021Fiscal year 2021: Operating cash flow 908.8M USD · Capital expenditure 107.6M USD · Free cash flow 801.2M USD
2022Fiscal year 2022: Operating cash flow 859.1M USD · Capital expenditure 121.2M USD · Free cash flow 737.8M USD
2023Fiscal year 2023: Operating cash flow 965.9M USD · Capital expenditure 105.3M USD · Free cash flow 860.6M USD
2024Fiscal year 2024: Operating cash flow 968.3M USD · Capital expenditure 103.9M USD · Free cash flow 864.4M USD
2025Fiscal year 2025: Operating cash flow 955.8M USD · Capital expenditure 107.1M USD · Free cash flow 848.6M USD
Share count
The share count fell in 5 years by 14.6% (mostly through share repurchases).
Diluted share count
010M20M30M
2016Fiscal year 2016: Diluted share count 27.0M
2017Fiscal year 2017: Diluted share count 26.4M
2018Fiscal year 2018: Diluted share count 25.8M
2019Fiscal year 2019: Diluted share count 25.0M
2020Fiscal year 2020: Diluted share count 24.2M
2021Fiscal year 2021: Diluted share count 23.5M
2022Fiscal year 2022: Diluted share count 22.7M
2023Fiscal year 2023: Diluted share count 22.0M
2024Fiscal year 2024: Diluted share count 21.3M
2025Fiscal year 2025: Diluted share count 20.7M
From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.
Metrics chart
Metrics chartUp to three metrics stacked, each with its own axis, over the same fiscal years. Optionally a second stock (dashed or hatched) and today’s sector median as a mark in the latest year – we do not have earlier medians.Example: Revenue rises, net margin falls, share count falls → more business, less profit per unit of revenue, fewer shares (mostly through buybacks).More in the Academy: Guide fundamental analysis
Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.
No annual figures for this stock: Dividend per share, Payout ratio (earnings), Payout ratio (free cash flow).
Source: SEC filings, fiscal years up to Dec 31, 2025. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.
How reliable is the dividend?
Dividend at a glance
The company pays no dividend.
As of fiscal year 2025 · Source: SEC filings
Valued higher or lower than usual?
Valuation against its own history
Valuation against its own historyWhere P/E, P/S or price/free cash flow stands today compared with the median of the company’s own last 5 fiscal years, in percent. Up to 10% deviation counts as “about at the median”. Describes only the position, not a judgement on an appropriate price.Example: P/E today 22, own 5-year median 27 → 22 ÷ 27 − 1 = −18.5%, so below the median.More in the Academy: Lesson cheaper or pricier than usual?
The P/E is above its own median of the 5 fiscal years before.
With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation.Sign up free
Source: SEC filings and our daily candles
Dividends and share repurchases
How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.
Dividend per share
nonepays no dividend
To shareholders (5 years)
4.6B USD100% through repurchases
Share count over 5 years
−14.6%fewer shares – each share is a larger stake
What goes back to shareholders
Over 5 years, 4.6B USD went back to shareholders, 100% of it through share repurchases. That is 113% of the free cash flow of those years.
2016Fiscal year 2016: Dividends paid not available · Share repurchases 500.0M USD · New shares issued (including employee plans) not available · Free cash flow 319.1M USD
2017Fiscal year 2017: Dividends paid not available · Share repurchases 400.0M USD · New shares issued (including employee plans) not available · Free cash flow 388.9M USD
2018Fiscal year 2018: Dividends paid not available · Share repurchases 475.0M USD · New shares issued (including employee plans) not available · Free cash flow 422.3M USD
2019Fiscal year 2019: Dividends paid not available · Share repurchases 775.0M USD · New shares issued (including employee plans) not available · Free cash flow 506.1M USD
2020Fiscal year 2020: Dividends paid not available · Share repurchases 775.0M USD · New shares issued (including employee plans) not available · Free cash flow 632.2M USD
2021Fiscal year 2021: Dividends paid not available · Share repurchases 1,000.0M USD · New shares issued (including employee plans) not available · Free cash flow 801.2M USD
2022Fiscal year 2022: Dividends paid not available · Share repurchases 1.1B USD · New shares issued (including employee plans) not available · Free cash flow 737.8M USD
2023Fiscal year 2023: Dividends paid not available · Share repurchases 900.0M USD · New shares issued (including employee plans) not available · Free cash flow 860.6M USD
2024Fiscal year 2024: Dividends paid not available · Share repurchases 850.0M USD · New shares issued (including employee plans) not available · Free cash flow 864.4M USD
2025Fiscal year 2025: Dividends paid not available · Share repurchases 800.0M USD · New shares issued (including employee plans) not available · Free cash flow 848.6M USD
Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.
Valuation over time
Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.Log in
Sector comparison
Mettler Toledo next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.
Sector comparison MTD, sector Health Care; last row: sector median
Figures of the last fiscal year from SEC annual reports (peers as of Nov 22, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 26 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light yellow: below sector
+5.5%per year, last 5 years
Sector Health Care: median +8.5% (25 symbols)
What does this mean? Revenue: over 5 years it grew by 5.5% per year on average, but more slowly than the median company in the sector (+8.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: above sector
+7.6%per year, last 5 years
Sector Health Care: median +5.5% (20 symbols)
per share: +11.0% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 7.6% per year on average – at least as fast as the median company in the sector (+5.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue, 21.59 USD remained as profit – at least as much as the median company in the sector (13.9%). Five years ago the margin was 19.5%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light red: much higher
25.28latest balance sheet
Sector Health Care: median 0.66 (19 symbols)
What does this mean? For every 1 USD of equity there is 25.28 USD of financial debt – more than twice as much as the median company in the sector (0.66). More debt amplifies good and bad years alike.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light gray: none found
–Dividend / earnings per share
Sector Health Care: median 56% (16 symbols)
What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light green: profit every year
10 of 10fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
4.0B USD
Revenue vs. prior year
+4.0%
Net income (FY)
869.2M USD
Net income vs. prior year
+0.7%
EPS (FY)
42.05 USD
Superinvestors holding
4 of 26
Fiscal year to Dec 31, 2025 · 10-K filed Feb 6, 2026 · Balance sheet Sep 30, 2026 (filed Nov 6, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2025
Dec 31, 2025
4.0B
869.2M
21.6%
42.05
–
–
2024
Dec 31, 2024
3.9B
863.1M
22.3%
40.48
–
–
2023
Dec 31, 2023
3.8B
788.8M
20.8%
35.90
–
–
2022
Dec 31, 2022
3.9B
872.5M
22.3%
38.41
–
–
2021
Dec 31, 2021
3.7B
769.0M
20.7%
32.78
–
–
2020
Dec 31, 2020
3.1B
602.7M
19.5%
24.91
–
–
2019
Dec 31, 2019
3.0B
561.1M
18.6%
22.47
–
–
2018
Dec 31, 2018
2.9B
512.6M
17.5%
19.88
–
–
2017
Dec 31, 2017
2.7B
376.0M
13.8%
14.24
–
–
2016
Dec 31, 2016
2.5B
384.4M
15.3%
14.22
–
–
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q3/26
Sep 30, 2026
1.1B
246.0M
22.5%
12.29
–
–
Q2/26
Jun 30, 2026
1.0B
232.9M
22.7%
11.55
–
–
Q1/26
Mar 31, 2026
947.1M
169.5M
17.9%
8.33
–
–
Q4/25*
Dec 31, 2025
1.1B
285.8M
25.3%
–
–
–
Q3/25
Sep 30, 2025
1.0B
217.5M
21.1%
10.57
–
–
Q2/25
Jun 30, 2025
983.2M
202.3M
20.6%
9.76
–
–
Q1/25
Mar 31, 2025
883.7M
163.6M
18.5%
7.81
–
–
Q4/24*
Dec 31, 2024
1.0B
252.3M
24.1%
–
–
–
Q3/24
Sep 30, 2024
954.5M
211.5M
22.2%
9.96
–
–
Q2/24
Jun 30, 2024
946.8M
221.8M
23.4%
10.37
–
–
Q1/24
Mar 31, 2024
925.9M
177.5M
19.2%
8.24
–
–
Q4/23*
Dec 31, 2023
935.0M
184.8M
19.8%
–
–
–
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Information only – does not affect the other analysis methods, not investment advice.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
Aug 5, 2026Salice Thomas PDirectorOpen-market sale417 shares · $600.7K · SEC
Aug 3, 2026Salice Thomas PDirectorOpen-market sale415 shares · $599.5K · SEC
Aug 3, 2026Keller GerryOfficerOpen-market sale240 shares · $342.5K · SEC
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Which superinvestors hold Mettler Toledo?
Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.
Trend score –
We do not calculate a trend score for symbols in the extended universe.
Volatility and trend strength
ADX 14 (trend strength)–
Price change 60 days–
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.